Business news

    US markets mixed; Nvidia surged on Q2 results; BioNTech shares plunged on efficacy rate study

    Article Image
    Highlights
    • The Nasdaq closed 0.1% higher at 14,542 on Thursday.
    • Nvidia rallied 4% on strong Q2 results including 89% EPS growth.
    • BioNTech shares plunged 8% on scientist reports & U.K. study.

    The US markets closed mixed on Thursday as investor optimism was boosted by increasing numbers of strong quarterly earnings reports. Investors still remain wary though of the potential volatility to come caused by the Delta COVID-19 strain spreading at the same time the central bank is set to ease its bond buying program.

    The Dow Jones fell 0.19% to finish the trading day down 67 points to close at 34,894 points.

    The tech heavy NASDAQ rose 0.1% to finish the trading day up 16 points to close at 14,542 points with Netflix and Google gaining 4.18% and 0.25% respectively.

    One bitcoin is worth US$46,634 going into the Asian trading day.

    The Australian dollar is firm against the major currencies and is buying 71.47 US cents.

    Semiconductor producer Nvidia rallied 4% yesterday after releasing impressive second-quarter results. For the period, Nvidia posted revenue growth of 68% YoY to US$6.5bn, EPS up 89% to US$1.04/share and an 85% growth for sales in it gaming segment.

    Shares in BioNTech plunged more than 8% on Thursday after reports some scientists are criticising the U.S. government?s decision to proceed with a third booster shot of the mRNA based COVID-19 vaccines. Results from a U.K. study showed a rapid loss of efficacy by the Pfizer and BioNTech vaccine against the delta strain of COVID-19.

    And Amazon is reportedly planning to open department stores in Ohio and California using empty mall spaces it purchased to offer in-store try on options and testing of products before buying.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa